Current:Home > ContactDemocratic state attorneys general sue Biden administration over abortion pill rules-DB Wealth Institute B2 Reviews & Ratings
Democratic state attorneys general sue Biden administration over abortion pill rules
lotradecoin login View Date:2024-12-26 05:37:26
A coalition of state attorneys general is suing the Food and Drug Administration, accusing the agency of excessively regulating the abortion pill mifepristone.
Mifepristone was approved more than 20 years ago to induce first-trimester abortions in combination with a second drug, misoprostol. The lawsuit, filed in federal court in Washington state by a dozen Democratic state attorneys general, asks the FDA to lift additional layers of regulation above and beyond those for typical prescription drugs.
It accuses the FDA "singling out mifepristone...for a unique set of restrictions," and asks the court to declare the drug to be safe and effective, and invalidate the additional regulation, known as a Risk Evaluation and Mitigation Strategy or REMS.
In an interview with NPR, Washington state Attorney General Bob Ferguson, who co-led the suit, noted that the REMS has been applied only to a few dozen high-risk prescription drugs — such as fentanyl and other opioids.
Regarding mifepristone, "what we're asking the court to do is remove those restrictions and make access to this important medication more available to women across the country," Ferguson says.
Since it was approved in 2000, mifepristone has been the subject of heated political debate surrounding abortion. For years, reproductive rights advocates and major medical groups have pushed for removing the REMS. In recent years, the Biden administration has loosened some requirements, allowing the drug to be delivered by mail and making it easier for major pharmacies to eventually dispense the drug. But prescribers are still subject to additional rules such as special certification requirements.
The lawsuit comes as a federal judge in a separate case in Texas is considering whether to overturn the FDA's approval of the abortion drug, setting up the possibility of conflicting rulings by different federal judges.
"So you'll have two federal judges potentially looking at the future of mifepristone, whether to expand access to it or eliminate access altogether," Ferguson says.
He says the question of how to regulate mifepristone could end up before the U.S. Supreme Court.
In a statement to NPR, Erik Baptist, senior counsel with Alliance Defending Freedom, the anti-abortion legal group leading the mifepristone challenge in Texas, noted that a group of Democratic attorneys general filed a brief in that case supporting the FDA's approval of the drug.
"We find it highly ironic that the same attorneys general who filed an amicus brief in our case two weeks ago arguing that the FDA's judgments must not be second-guessed have now filed a lawsuit in a different court arguing just the exact opposite," Baptist says.
Major medical groups including the American College of Obstetricians and Gynecologists and the American Medical Association filed an amicus brief in the Texas case calling mifepristone "thoroughly studied" and "conclusively safe."
An FDA official says the agency does not comment on ongoing litigation.
veryGood! (86427)
Related
- As Baltimore’s Sewer System Buckles Under Extreme Weather, City Refuses to Help Residents With Cleanup Efforts
- Executions in Iran are up 30%, a new United Nations report says
- Texas Rangers win first World Series title with 5-0 win over Diamondbacks in Game 5
- Denmark drops cases against former defense minister and ex-spy chief charged with leaking secrets
- Rob Schneider Responds to Daughter Elle King Calling Out His Parenting
- Only debate of Mississippi governor’s race brings insults and interruptions from Reeves and Presley
- Trial to determine if Trump can be barred from offices reaches far back in history for answers
- Cornell student accused of threatening Jewish students held without bail after first court appearance
- Meta kills off misinformation tracking tool CrowdTangle despite pleas from researchers, journalists
- Donald Trump Jr. is testifying at the Trump fraud trial in New York. Here's what to know.
Ranking
- 'Business done right': Why the WWE-TNA partnership has been a success
- Teachers kick off strike in Portland, Oregon, over class sizes, pay and resources
- Joe Jonas Reacts When CVS Security Guard Says He “Looks Crazy”
- Mormon church sued again over how it uses tithing contributions from members
- Traveling? Here Are the Best Life-Saving Travel Accessories You Need To Pack, Starting at Just $7
- 2 flight attendants sue United Airlines for discrimination on Dodgers charter flights
- Harris and Sunak due to discuss cutting-edge AI risks at UK summit
- The Best Gifts for Harry Potter Fans That Are Every Potterhead’s Dream
Recommendation
-
A slain teacher loved attending summer camp. His mom is working to give kids the same opportunity
-
Chase Young trade is latest blockbuster pulled off by 49ers' John Lynch and Kyle Shanahan
-
House weighs censure efforts against Rashida Tlaib and Marjorie Taylor Greene over their rhetoric
-
Kendall Jenner's Wonder Woman Halloween Costume Gets the Ultimate Stamp of Approval From Lynda Carter
-
Ryan Reynolds on his 'complicated' relationship with his dad, how it's changed him
-
Lynyrd Skynyrd, ZZ Top announce 2024 tour with stops in 36 cities: See the list
-
Ole Miss coach Lane Kiffin dunks on Texas A&M's Jimbo Fisher as only Kiffin can
-
Washington Capitals' Nicklas Backstrom taking leave to evaluate his health